NCT05739942: Dose Finding Study of [177Lu]Lu-NeoB in Newly Diagnosed Glioblastoma and in Recurrent Glioblastoma |
|
|
| Recruiting | 1 | 48 | Europe, US, RoW | [177Lu]Lu-NeoB, Lu-NeoB, [68Ga]Ga-NeoB, Ga-NeoB, Temozolomide | Novartis Pharmaceuticals | Newly Diagnosed and Recurrent Glioblastoma | 02/26 | 08/31 | | |